Erthang, I agree that the technology appears not only good but fantastic and could definitely have a huge impact on health care. What I am concerned about is management doing things that are not in line with a company that is in possession of a technology that is worth "billions".
Why all the massive dilution of almost 10% of the company in October when money is thought to be very close from Abbott? How could a company of any caliber with the product they have end up with a connection to Lebed?
You can call me a basher or anything you like but there are things happening that remain unexplained. I agree that speculating that the test might be returned is only one reason that could explain all of the recent activity. There of couse could be other reasons or just plain bad management.
News 
Market Data 
Discover 
